Cargando…

Clinical implications of elevated serum soluble CD137 levels in patients with acute coronary syndrome

OBJECTIVES: Atherosclerosis is a chronic inflammatory disease. Research has focused on identifying specific serum biomarkers to detect vulnerable plaques. These markers serve as diagnostic tools for acute coronary syndrome and assist in identifying high-risk patients. However, the existing data are...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yan, Jinchuan, Wang, Cuiping, Chen, Rui, Yang, Haibing
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo 2013
Materias:	Clinical Science
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3584275/ https://www.ncbi.nlm.nih.gov/pubmed/23525315 http://dx.doi.org/10.6061/clinics/2013(02)OA12

Ejemplares similares

Increased Soluble CD137 Levels and CD4+ T‐Cell‐Associated Expression of CD137 in Acute Atherothrombotic Stroke
por: He, Yang, et al.
Publicado: (2018)

Soluble CD137 as a dynamic biomarker to monitor agonist CD137 immunotherapies
por: Glez-Vaz, Javier, et al.
Publicado: (2022)

Correction: Soluble CD137 as a dynamic biomarker to monitor agonist CD137 immunotherapies
Publicado: (2023)

CD137-CD137L Interaction Regulates Atherosclerosis via Cyclophilin A in Apolipoprotein E-Deficient Mice
por: Li, Yuefeng, et al.
Publicado: (2014)

CD137 Regulates NFATc1 Expression in Mouse VSMCs through TRAF6/NF-κB p65 Signaling Pathway
por: Yan, Jinchuan, et al.
Publicado: (2015)

Association Study between an SNP in CD147 and Its Expression With Acute Coronary Syndrome in a Jiangsu Chinese Population
por: Yan, Jinchuan, et al.
Publicado: (2015)

Elevated Serum Levels of Soluble ST2 Are Associated With Plaque Vulnerability in Patients With Non-ST-Elevation Acute Coronary Syndrome
por: Luo, Guqing, et al.
Publicado: (2021)

Hypoxia-induced soluble CD137 in malignant cells blocks CD137L-costimulation as an immune escape mechanism
por: Labiano, Sara, et al.
Publicado: (2014)

Activation of CD137 Signaling Promotes Angiogenesis in Atherosclerosis via Modulating Endothelial Smad1/5‐NFATc1 Pathway
por: Weng, Jiayi, et al.
Publicado: (2017)

Elevated serum levels of soluble CD154 in children with juvenile idiopathic arthritis
por: Prahalad, Sampath, et al.
Publicado: (2008)

CD137-CD137 Ligand Interactions in Inflammation
por: Kwon, Byungsuk
Publicado: (2009)

Soluble CD137 as a potential biomarker for severe COVID-19
por: Marques, Mariana de Oliveira, et al.
Publicado: (2022)

Soluble CD137 Ameliorates Acute Type 1 Diabetes by Inducing T Cell Anergy
por: Itoh, Arata, et al.
Publicado: (2019)

Red blood cell distribution width is associated with myocardial injury in non-ST-elevation acute coronary syndrome
por: Tenekecioglu, Erhan, et al.
Publicado: (2015)

Membrane and Soluble CD137 in Systemic Lupus Erythematosus: Role as Biomarkers for Disease Activity
por: Ceccarelli, Fulvia, et al.
Publicado: (2023)

Angiographically Based Direct Implantation of the Bioresorbable Vascular Scaffold in Non-ST Segment Elevation Acute Coronary Syndrome: Feasibility and Outcome
por: Nour, Mahmoud Khaled, et al.
Publicado: (2019)

Association between serum S100A1 level and Global Registry of Acute Coronary Events score in patients with non-ST-segment elevation acute coronary syndrome
por: Li, Yuanmin, et al.
Publicado: (2018)

Elevated serum level of hepatocyte growth factor predicts development of new syndesmophytes in men with ankylosing spondylitis
por: Deminger, Anna, et al.
Publicado: (2020)

Activating CD137 Signaling Promotes Sprouting Angiogenesis via Increased VEGFA Secretion and the VEGFR2/Akt/eNOS Pathway
por: Li, Bo, et al.
Publicado: (2020)

Association of elevated serum soluble CD226 levels with the disease activity and flares of systemic lupus erythematosus
por: Nakano, Miki, et al.
Publicado: (2021)

Serum Calprotectin Levels and Outcome Following Percutaneous Coronary Intervention in Patients with Diabetes and Acute Coronary Syndrome
por: Wang, Chengji, et al.
Publicado: (2019)

Outcomes in patients with non-ST-elevation acute coronary syndrome randomly assigned to invasive versus conservative treatment strategies: A meta-analysis
por: Li, Ying-Qing, et al.
Publicado: (2014)

Exosome derived from CD137‐modified endothelial cells regulates the Th17 responses in atherosclerosis
por: Xu, Liangjie, et al.
Publicado: (2020)

Elevated Levels of Serum Pentosidine Are Associated with Dropped Head Syndrome in Older Women
por: Eguchi, Yawara, et al.
Publicado: (2019)

Is CD137 Ligand (CD137L) Signaling a Fine Tuner of Immune Responses?
por: Kwon, Byungsuk
Publicado: (2015)

Diagnostic value of lymphopaenia and elevated serum ACE in patients with uveitis
por: Cotte, Philippine, et al.
Publicado: (2021)

Soluble CD40 Ligand Stimulates CD40-Dependent Activation of the β2 Integrin Mac-1 and Protein Kinase C Zeda (PKCζ) in Neutrophils: Implications for Neutrophil-Platelet Interactions and Neutrophil Oxidative Burst
por: Jin, Rong, et al.
Publicado: (2013)

Adult T-cell leukemia/lymphoma following elevation of serum levels of soluble cytokine receptors, sCD25 and sCD30
por: Takemoto, Shigeki, et al.
Publicado: (2014)

Elevated serum transaminases in patients with acute coronary syndromes: Do we need a revision of exclusion criteria for clinical trials?
por: Jasiewicz, Małgorzata, et al.
Publicado: (2023)

Regulatory T Cells Inhibit T Cell Activity by Downregulating CD137 Ligand via CD137 Trogocytosis
por: Luu, Khang, et al.
Publicado: (2021)

The Murine CD137/CD137 Ligand Signalosome: A Signal Platform Generating Signal Complexity
por: Choi, Beom K., et al.
Publicado: (2020)

Relation of Elevated Serum Uric Acid Level to Endothelial Dysfunction in Patients with Acute Coronary Syndrome
por: Saito, Yuichi, et al.
Publicado: (2019)

Elevated Serum Levels of Soluble CD30 in Ankylosing Spondylitis Patients and Its Association with Disease Severity-Related Parameters
por: Gao, Rongfen, et al.
Publicado: (2015)

The Roles of CD137 Signaling in Atherosclerosis
por: Jung, In-Hyuk, et al.
Publicado: (2016)

Association of serum cystatin C levels with acute coronary syndrome in patients of advanced age
por: Huang, Qingyu, et al.
Publicado: (2019)

Serum CA72-4 is specifically elevated in gout patients and predicts flares
por: Bai, Xueshan, et al.
Publicado: (2020)

Predictive Value of Hematologic Indices in the Diagnosis of Acute Coronary Syndrome
por: Luke, Kevin, et al.
Publicado: (2019)

Enhancement of soluble CD28 levels in the serum of Graves’ disease
por: Sun, Zhongwen, et al.
Publicado: (2014)

The Progress of Investigating the CD137-CD137L Axis as a Potential Target for Systemic Lupus Erythematosus
por: Mak, Anselm, et al.
Publicado: (2019)

Contributions of Costimulatory Molecule CD137 in Endothelial Cells
por: Yuan, Wei, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_78umqhlt7kqtk2o7snoik0tbub